Skip to content

Total Assets at other companies

Eli Lilly logo
Eli LillyLLY
$116.58B+30.4%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$200.89B+3.7%
Amgen logo
AmgenAMGN
$92.5B+3.5%
AbbVie logo
AbbVieABBV
$136.46B+0.2%
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
$198.72M+0.3%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$99.89M-27.9%

Other financials

Income statement

See full
Revenue-
Operating income-$15.5M-8.0%
Net income-$14.8M-7.8%
EPS (diluted)-$0.13+51.9%

Balance sheet

See full
Cash & equivalents$90.4M+48.5%
Total debt$2.9M-9.5%
Total equity$95.8M+41.8%

Cash flow

See full
Operating cash flow-$13.4M-11.6%
CapEx$63.0K
Free cash flow-$13.5M-12.1%

Valuation

See full
Market cap$564.45M+1,131%
Enterprise value$476.92M-4,119%
P/S564.5×+554×

Profitability

See full
Operating margin-5,266.4%-9,520pp
Net margin-4,987.4%-8,966pp
FCF margin-4,140.8%-7,144pp

Returns & leverage

See full
Return on equity-61%-8.0pp
Debt / equity0.0×
Current ratio22.1×+13.0×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Shattuck Labs, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Shattuck Labs, Inc.'s total assets?
Shattuck Labs, Inc. (STTK) reported total assets of $102.12M in Q1 2026.
How has Shattuck Labs, Inc.'s total assets changed year-over-year?
Shattuck Labs, Inc.'s total assets increased by 32.3% year-over-year, from $77.17M to $102.12M.
What is the long-term trend for Shattuck Labs, Inc.'s total assets?
Over 5 years (2020 to 2025), Shattuck Labs, Inc.'s total assets has grown at a -23.6% compound annual growth rate (CAGR), from $348.99M to $91.03M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.